Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea Reveals More On Plans To Grow Bioclusters At Osong And Daegu

This article was originally published in PharmAsia News

Executive Summary

SEOUL - The Korean government announced more details on how it plans to cultivate its multibillion dollar, high-tech pharmaceutical R&D projects in Osong and Daegu
Advertisement

Related Content

Samsung Looks To Mirror Fellow Korean Pharma Celltrion's Path From CMO To Biosimilars Developer With Quintiles JV
And The Winner Is? Two Cities For The Price Of One Win Bid For Multi-billion Dollar Korean Biopolis
And The Winner Is? Two Cities For The Price Of One Win Bid For Multi-billion Dollar Korean Biopolis
South Korea Will Not Pursue Compulsory Licensing Against MNCs, But For How Long?
Korea Targets Biologics, Devices, Health Care Among Economic Growth Projects For Next Decade
Advertisement
UsernamePublicRestriction

Register

SC077459

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel